Authors:
Shen, P
Guenther, JM
Wanek, LA
Morton, DL
Citation: P. Shen et al., Can elective lymph node dissection decrease the frequency and mortality rate of late melanoma recurrences?, ANN SURG O, 7(2), 2000, pp. 114-119
Authors:
Essner, R
Huynh, Y
Nguyen, T
Morton, DL
Hoon, DSB
Citation: R. Essner et al., Functional interleukin 4 receptor and interleukin 2 receptor common gamma-chain on human non-small cell lung cancers: Novel targets for immune therapy, J THOR SURG, 119(1), 2000, pp. 10-20
Authors:
Hoon, DSB
Bostick, P
Kuo, C
Okamoto, T
Wang, HJ
Elashoff, R
Morton, DL
Citation: Dsb. Hoon et al., Molecular markers in blood as surrogate prognostic indicators of melanoma recurrence, CANCER RES, 60(8), 2000, pp. 2253-2257
Authors:
Cochran, AJ
Balda, BR
Starz, H
Bachter, D
Krag, DN
Cruse, CW
Pijpers, R
Morton, DL
Citation: Aj. Cochran et al., The Augsburg consensus - Techniques of lymphatic mapping, sentinel lymphadenectomy, and completion lymphadenectomy in cutaneous malignancies, CANCER, 89(2), 2000, pp. 236-241
Authors:
Balch, CM
Buzaid, AC
Atkins, MB
Cascinelli, N
Coit, DG
Fleming, ID
Houghton, A
Kirkwood, JM
Mihm, MF
Morton, DL
Reintgen, D
Ross, MI
Sober, A
Soong, SJ
Thompson, JA
Thompson, JF
Gershenwald, JE
McMasters, KM
Citation: Cm. Balch et al., A new American Joint Committee on Cancer staging system for cutaneous melanoma, CANCER, 88(6), 2000, pp. 1484-1491
Authors:
Bilchik, AJ
Wood, TF
Allegra, D
Tsioulias, GJ
Chung, M
Rose, DM
Ramming, KP
Morton, DL
Citation: Aj. Bilchik et al., Cryosurgical ablation and radiofrequency ablation for unresectable hepaticmalignant neoplasms - A proposed algorithm, ARCH SURG, 135(6), 2000, pp. 657-662
Citation: Aj. Cochran et al., Surgical pathology of dye-directed selective lymph node dissection, LYMPHATIC MAPPING AND PROBE APPLICATIONS IN ONCOLOGY, 2000, pp. 125-139
Authors:
Kelemen, PR
Essner, R
Foshag, LJ
Morton, DL
Citation: Pr. Kelemen et al., Lymphatic mapping and sentinel lymphadenectomy after wide local excision of primary melanoma, J AM COLL S, 189(3), 1999, pp. 247-252
Citation: Dl. Morton et Ad. Chan, Current status of intraoperative lymphatic mapping and sentinel lymphadenectomy for melanoma: Is it standard of care?, J AM COLL S, 189(2), 1999, pp. 214-223
Authors:
Haigh, PI
Essner, R
Wardlaw, JC
Stern, SL
Morton, DL
Citation: Pi. Haigh et al., Long-term survival after complete resection of melanoma metastatic to the adrenal gland, ANN SURG O, 6(7), 1999, pp. 633-639
Authors:
DiFronzo, LA
Wanek, LA
Elashoff, R
Morton, DL
Citation: La. Difronzo et al., Increased incidence of second primary melanoma in patients with a previouscutaneous melanoma, ANN SURG O, 6(7), 1999, pp. 705-711
Authors:
Essner, R
Conforti, A
Kelley, MC
Wanek, L
Stern, S
Glass, E
Morton, DL
Citation: R. Essner et al., Efficacy of lymphatic mapping, sentinel lymphadenectomy, and selective complete lymph node dissection as a therapeutic procedure for early-stage melanoma, ANN SURG O, 6(5), 1999, pp. 442-449
Citation: Pr. Kelemen et al., Lymph node biopsy does not impair survival after therapeutic dissection for palpable melanoma metastases, ANN SURG O, 6(2), 1999, pp. 139-143